Furthermore, rare germline genomic duplications and deletions have been shown to disrupt high-penetrance tumor suppressor genes, such as the BRCA1 and BRCA2 genes, in breast cancer patients, and have been demonstrated to aggregate within families [18–20]. The gene discussed is BRCA1; the disease is breast cancer.